Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1995 | |
| Sales | 30,192,120 |
| Cost of Goods | 12,783,120 |
| Gross Profit | 17,409,000 |
| Operating Expenses | 12,609,360 |
| Operating Income | 4,799,760 |
| Other Income | -115,920 |
| Pre-tax Income | 4,683,840 |
| Income Tax | 1,132,320 |
| Net Income Continuous | 3,541,440 |
| Net Income | $3,541,440 |
| EPS Basic Total Ops | 2.54 |
| EPS Basic Continuous Ops | 2.54 |
| EBITDA(a) | $4,799,760 |